DNAzyme-adsorbed polydopamine@MnO


Journal

Nanoscale
ISSN: 2040-3372
Titre abrégé: Nanoscale
Pays: England
ID NLM: 101525249

Informations de publication

Date de publication:
12 Mar 2021
Historique:
pubmed: 3 3 2021
medline: 15 5 2021
entrez: 2 3 2021
Statut: ppublish

Résumé

Photothermal therapy (PTT) is a promising tumor treatment modality, but its efficacy is strictly hindered by abnormally upregulated heat shock proteins (HSPs) in tumor cells under heat stress. Herein, we developed a flower-like MnO2-coated polydopamine (PDA@MnO2) core-shell nanoplatform with the surface adsorption of HSP70-silencing DNAzyme (DZ) for enhanced PPT. The PDA core acted as a robust photothermal agent, and also as a reductant to allow the surface growth of MnO2via an in situ reduction of KMnO4. The MnO2 shell enabled a rapid and efficient adsorption of DZ, and more importantly, acted as a metal reservoir to release Mn2+ in response to intracellular stimuli for the in situ activation of DZ, which addressed the key limitation of DZ for biological applications, i.e., metal-dependent activity. As a result, HSP70 was remarkably suppressed for improved PTT efficacy upon laser irradiation, which was explicitly demonstrated both in vitro and in vivo. Upon intravenous injection, the nanosystem could effectively accumulate in the tumor, and impose potent PTT for complete tumor elimination via inducing tumor cell apoptosis, but without any noticeable toxicity. This work provides a promising nanosystem for enhanced PTT via silencing resistance-related genes, and offers ideas for the design of self-activated gene therapy platforms using DZ.

Identifiants

pubmed: 33651054
doi: 10.1039/d0nr08845e
doi:

Substances chimiques

DNA, Catalytic 0
HSP70 Heat-Shock Proteins 0
Indoles 0
Manganese Compounds 0
Oxides 0
Polymers 0
polydopamine 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5125-5135

Auteurs

Yang Xi (Y)

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China. zhouwenhuyaoji@163.com.

Xin Xie (X)

School of Pharmaceutical Sciences, Gannan Medical University, Ganzhou 341000, China.

Ying Peng (Y)

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China. zhouwenhuyaoji@163.com.

Peng Liu (P)

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China. zhouwenhuyaoji@163.com.

Jinsong Ding (J)

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China. zhouwenhuyaoji@163.com.

Wenhu Zhou (W)

Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan 410013, China. zhouwenhuyaoji@163.com and Academician Workstation, Changsha Medical University, Changsha 410219, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH